i-Tracker: For quantitative proteomics using iTRAQ (TM)

Autor: Shadforth, IP, Dunkley, TPJ, Lilley, KS, Bessant, C

Background: iTRAQ(TM) technology for protein quantitation using mass spectrometry is a recent, powerful means of determining relative protein levels in up to four samples simultaneously. Although protein identification of samples generated using iTRA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______109::53ec2390788a0e88844c285783a179bc
http://www.dspace.cam.ac.uk/handle/1810/238088

Clinical Validation of a Machine-Learned, Point-of-Care System to IDENTIFY Functionally Significant Coronary Artery Disease.

Autor: Stuckey TD; Cone Health Heart and Vascular Center, Greensboro, NC 27401, USA., Meine FJ; Novant Health New Hanover Regional Medical Center, Wilmington, NC 28401, USA., McMinn TR; Austin Heart, Austin, TX 78705, USA., Depta JP; Rochester General Hospital, Rochester, NY 14621, USA., Bennett BA; Jackson Heart Clinic, Jackson, MS 39216, USA., McGarry TF; Oklahoma Heart Hospital, Oklahoma City, OK 73120, USA., Carroll WS; Cardiology Associates of North Mississippi, Tupelo, MS 38801, USA., Suh DD; Atlanta Heart Specialists, Tucker, GA 30084, USA., Steuter JA; Bryan Heart, Lincoln, NE 68506, USA., Roberts MC; Lexington Medical Center Heart & Vascular, West Columbia, SC 29169, USA., Gillins HR; CorVista Health, Inc., Bethesda, MD 20814, USA., Fathieh F; Analytics for Life, Inc., Toronto, ON M5X 1C9, Canada., Burton T; Analytics for Life, Inc., Toronto, ON M5X 1C9, Canada., Nemati N; Analytics for Life, Inc., Toronto, ON M5X 1C9, Canada., Shadforth IP; CorVista Health, Inc., Bethesda, MD 20814, USA., Ramchandani S; Analytics for Life, Inc., Toronto, ON M5X 1C9, Canada., Bridges CR; CorVista Health, Inc., Bethesda, MD 20814, USA., Rabbat MG; Loyola University Medical Center, Maywood, IL 60153, USA.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 May 08; Vol. 14 (10). Date of Electronic Publication: 2024 May 08.

Machine Learning Algorithms: Selection of Appropriate Validation Populations for Cardiology Research-Be Careful!

Autor: Sanders WE Jr; CorVista Health, Inc, Washington, DC, USA.; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Khedraki R; Scripps Clinic, San Diego, California, USA., Rabbat M; Loyola University Medical Center, Maywood, Illinois, USA., McMinn TR; Austin Heart, Austin, Texas, USA., Burton T; CorVista Health, Toronto, Ontario, Canada., Khosousi A; CorVista Health, Toronto, Ontario, Canada., Fathieh F; CorVista Health, Toronto, Ontario, Canada., Gillins HR; CorVista Health, Inc, Washington, DC, USA., Ramchandani S; CorVista Health, Toronto, Ontario, Canada., Shadforth IP; CorVista Health, Inc, Washington, DC, USA.

Publikováno v: JACC. Advances [JACC Adv] 2023 Jan 11; Vol. 2 (1), pp. 100166. Date of Electronic Publication: 2023 Jan 11 (Print Publication: 2023).

Quantitative proteomic approach to study subcellular localization of membrane proteins.

Autor: Sadowski PG; Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Downing Site, Cambridge CB2 1QW, UK., Dunkley TP, Shadforth IP, Dupree P, Bessant C, Griffin JL, Lilley KS

Publikováno v: Nature protocols [Nat Protoc] 2006; Vol. 1 (4), pp. 1778-89.